REGULATORY FUNCTIONS OF INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS IN OSTEOARTHRITIS

被引:9
作者
Galasso, O. [1 ]
De Gori, M. [1 ]
Nocera, A. [2 ]
Brunetti, A. [2 ]
Gasparini, G. [1 ]
机构
[1] Magna Graecia Univ Catanzaro, Dept Orthopaed & Trauma Surg, I-88100 Catanzaro, Italy
[2] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, I-88100 Catanzaro, Italy
关键词
Cartilage; IGFs; Insulin-like Growth Factor Binding Proteins; Osteoarthritis; HUMAN ARTICULAR-CARTILAGE; I IGF-I; SYNOVIAL-FLUID; FACTOR BINDING-PROTEIN-3; CHONDROCYTES; PROTEOLYSIS; IGFBP-3; EXPRESSION; INSULIN-LIKE-GROWTH-FACTOR-1; PROTEOGLYCAN;
D O I
10.1177/03946320110241S211
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Insulin-like growth factor binding proteins (IGFBPs) are a group of secreted proteins, which bind to IGF-I (and IGF-II) with high affinity and modulate the biological actions of IGFs. Abundant evidence points the importance of the IGF-I/IGFBP system on both cell growth and differentiation. A role for the IGF-I/IGFBP system in the regulation of normal human cartilage has been previously reported. In this context, recent studies suggest an emerging role for IGFBPs in the failure of cartilage during osteoarthritis (OA). Indeed, increased IGFBP levels have been reported in both the articular cartilage and synovial fluid from patients with OA. Overexpression of IGFBPs, by altering the bioavailability and function of IGFs, is likely to deliver IGFs-independent signals for chondrocyte survival. This, at least in part, might explain the degenerative changes of the cartilage in OA. Further studies are necessary to clarify the mechanisms that cause the overexpression of IGFBPs in patients with OA. Advances in our understanding of the relationship between osteoarthritis and the IGF-I/IGFBP system may lead to new treatment strategies for this degenerative disease.
引用
收藏
页码:55 / 59
页数:5
相关论文
共 38 条
[1]   The insulin-like growth factors (IGFs) I and II bind to articular cartilage via the IGF-binding proteins [J].
Bhakta, NR ;
Garcia, AM ;
Frank, EH ;
Grodzinsky, AJ ;
Morales, TI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (08) :5860-5866
[2]   IN-VIVO PROTEOLYSIS OF SERUM INSULIN-LIKE GROWTH-FACTOR (IGF) BINDING PROTEIN-3 RESULTS IN INCREASED AVAILABILITY OF IGF TO TARGET-CELLS [J].
BLAT, C ;
VILLAUDY, J ;
BINOUX, M .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (05) :2286-2290
[3]  
Burren CP, 1999, J CLIN ENDOCR METAB, V84, P1096
[4]  
Chevalier X, 1996, BRIT J RHEUMATOL, V35, P515
[5]   Inhibition of insulin-like growth factor binding protein 5 proteolysis in articular cartilage and joint fluid results in enhanced concentrations of insulin-like growth factor 1 and is associated with improved osteoarthritis [J].
Clemmons, DR ;
Busby, WH ;
Garmong, A ;
Schultz, DR ;
Howell, DS ;
Altman, RD ;
Karr, R .
ARTHRITIS AND RHEUMATISM, 2002, 46 (03) :694-703
[6]   Factors regulating insulin-like growth factor-binding protein 3 binding, processing, and potentiation of insulin-like growth factor action [J].
Conover, CA ;
Clarkson, JT ;
Bale, LK .
ENDOCRINOLOGY, 1996, 137 (06) :2286-2292
[7]   Pharmacological disruption of insulin-like growth factor 1 binding to IGF-binding proteins restores anabolic responses in human osteoarthritic chondrocytes [J].
De Ceuninck, F ;
Caliez, A ;
Dassencourt, L ;
Anract, P ;
Renard, P .
ARTHRITIS RESEARCH & THERAPY, 2004, 6 (05) :R393-R403
[8]  
DiBattista JA, 1997, J CELL BIOCHEM, V65, P408, DOI 10.1002/(SICI)1097-4644(19970601)65:3<408::AID-JCB10>3.3.CO
[9]  
2-H
[10]   Human Acid-Labile Subunit Deficiency: Clinical, Endocrine and Metabolic Consequences [J].
Domene, Horacio M. ;
Hwa, Vivian ;
Argente, Jesus ;
Wit, Jaan M. ;
Camacho-Huebner, Cecilia ;
Jasper, Hector G. ;
Pozo, Jesus ;
van Duyvenvoorde, Hermine A. ;
Yakar, Shoshana ;
Fofanova-Gambetti, Olga V. ;
Rosenfeld, Ron G. .
HORMONE RESEARCH, 2009, 72 (03) :129-141